ClariVest Asset Management LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 168 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$290
-34.4%
66,9680.0%0.02%
-27.3%
Q2 2023$442
+53.5%
66,968
+57.6%
0.02%
+69.2%
Q1 2023$288
-8.3%
42,487
-0.0%
0.01%
-13.3%
Q4 2022$314
-99.9%
42,500
-1.6%
0.02%
-28.6%
Q3 2022$427,000
+33.4%
43,200
+46.9%
0.02%
+50.0%
Q2 2022$320,000
-3.6%
29,4000.0%0.01%
+7.7%
Q1 2022$332,000
-36.8%
29,400
-12.1%
0.01%
-18.8%
Q4 2021$525,000
-10.1%
33,437
-1.8%
0.02%
-15.8%
Q3 2021$584,000
-20.5%
34,037
-0.3%
0.02%
-20.8%
Q2 2021$735,000
+43.3%
34,1370.0%0.02%
+33.3%
Q1 2021$513,000
-36.6%
34,137
-44.7%
0.02%
-35.7%
Q4 2020$809,000
-18.3%
61,692
-39.8%
0.03%
-12.5%
Q3 2020$990,000
-40.2%
102,465
-29.2%
0.03%
-28.9%
Q2 2020$1,655,000
+9.8%
144,658
-0.6%
0.04%0.0%
Q1 2020$1,507,000
-22.5%
145,505
+22.8%
0.04%0.0%
Q4 2019$1,944,000
-0.1%
118,465
-19.1%
0.04%
+2.3%
Q3 2019$1,946,000
+21.5%
146,430
+28.9%
0.04%
+22.2%
Q2 2019$1,601,000
-24.1%
113,630
-0.9%
0.04%
-16.3%
Q1 2019$2,110,000
+106.5%
114,647
+193.0%
0.04%
+95.5%
Q4 2018$1,022,000
+9.5%
39,128
-3.8%
0.02%
+29.4%
Q3 2018$933,000
+20.4%
40,6780.0%0.02%
+30.8%
Q2 2018$775,000
-1.1%
40,678
-12.7%
0.01%
-7.1%
Q1 2018$784,000
+12.3%
46,578
+1.3%
0.01%
+16.7%
Q4 2017$698,000
+552.3%
45,999
+666.8%
0.01%
+500.0%
Q3 2017$107,000
+13.8%
5,999
+4.0%
0.00%0.0%
Q2 2017$94,000
+16.0%
5,7670.0%0.00%0.0%
Q1 2017$81,0005,7670.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders